Rady Children's Specialists of San Diego
Cantonese, Mandarin, Spanish
University of California - San Diego
UC San Diego
Saint Louis University School of Medicine
Rady Children's Hospital-San Diego
Dermatology, Pediatric Dermatology
Dr. Wynnis Tom is a dermatologist at Rady Children's Hospital-San Diego and a professor in the Departments of Dermatology and Pediatrics at UC San Diego.
Dr. Tom graduated from Stanford University, then earned her medical degree from UC San Diego School of Medicine. After completing her residency at Saint Louis University, she returned to San Diego to pursue a fellowship in pediatric dermatology and has since been an active faculty member in the Dermatology Division at Rady Children's.
Dr. Tom cares for patients in the Severe Inflammatory Dermatoses/Systemic Therapy Clinic. Her special clinical interests include chronic inflammatory skin disorders, particularly atopic dermatitis (eczema) and psoriasis, and managing patients with diseases that require oral or systemic medicines. Her research focuses on the genetic factors contributing to these difficult-to-treat diseases, patient response to treatment, and complications such as secondary infections and cardiac health risks.
Dr. Tom enjoys searching for new cuisine or restaurants around San Diego, traveling, spending time with family, and is addicted to tapioca tea.
Diffuse Geometric Erosions on the Skin of a Premature Infant, Fraternal Twin Unaffected.
Natsis N, Soeprono F, Nelson A, Barrio VR, Tom WL
Heterogeneous cutaneous findings associated with intrauterine HSV infection: A case series and literature review.
Pithadia DJ, Kerns ML, Golden WC, Balagula Y, Glick SA, Huang A, Natsis NE, Tom WL, Cohen BA
Relationship Among Treatment, Pruritus, Investigator's Static Global Assessment, and Quality of Life in Patients with Atopic Dermatitis.
Simpson EL, Tom WL, Bushmakin AG, Cappelleri JC, Yosipovitch G, StÃ¤nder S, Luger T, Sanders P, Gerber RA, Myers DE
Congenital cutaneous non-neural granular cell tumor mimicking herpetic infection: Case report and review of the literature.
Mancuso JB, Haddock ES, Tucker S, Newbury R, Hinds B, Tom WL
Body site distribution of pediatric-onset morphea and association with extracutaneous manifestations.
Chiu YE, Shmuylovich L, Kiguradze T, Anderson K, Sibbald C, Tollefson M, Kunzler E, Tom WL, Bond K, Ahmad RC, Garcia-Romero MT, Irfan M, Kollman K, Hunt R, Stein SL, Arkin L, Wong V, Pope E, Jacobe H, Brandling-Bennett HA, Cordoro KM, Bercovitch L, Rangel SM, Liu X, Szabo A, Paller AS
Resolution of chronic recurrent pyoderma gangrenosum with latent tuberculosis treatment.
Saklecha A, Tom W, Sprague J
Combined Intravenous Sildenafil and L-Arginine Administration in a Porcine Animal Model: Hemodynamic Safety Profile and Effects on Coronary Blood Flow.
Brzezinski M, Dincheva GR, Alloo K, Wong C, Feng CM, Tom WL, Salahieh A, Wallace AW
Systemic immunosuppressive therapy for inflammatory skin diseases in children: Expert consensus-based guidance for clinical decision-making during the COVID-19 pandemic.
Reynolds SD, Mathur AN, Chiu YE, Brandling-Bennett HA, Pope E, Siegel MP, Holland KE, Paller AS, Siegfried EC, Tom WL, Lara-Corrales I, Tollefson MM, Maguiness S, Eichenfield LF, Sugarman J, Frieden IJ, Oza VS, Cipriano SD, Huang JT, Shah SD, Lauren CT, Castelo-Soccio L, McMahon P, Cordoro KM
A Comparison of Psoriasis Severity in Pediatric Patients Treated With Methotrexate vs Biologic Agents.
Bronckers IMGJ, Paller AS, West DP, Lara-Corrales I, Tollefson MM, Tom WL, Hogeling M, Belazarian L, Zachariae C, MahÃ© E, Siegfried E, Blume-Peytavi U, Szalai Z, Vleugels RA, Holland K, Murphy R, Puig L, Cordoro KM, Lambert J, Alexopoulos A, Mrowietz U, Kievit W, Seyger MMB, Psoriasis Investigator Group, the Pediatric Dermatology Research Alliance, and the European Working Group on Pediatric Psoriasis.
Direct and Indirect Effects of Crisaborole Ointment on Quality of Life in Patients with Atopic Dermatitis: A Mediation Analysis.
Simpson EL, Yosipovitch G, Bushmakin AG, Cappelleri JC, Luger T, StÃ¤nder S, Tom WL, Ports WC, Zielinski MA, Tallman AM, Tan H, Gerber RA
Developing drugs for treatment of atopic dermatitis in children (â‰¥3 months to <18 years of age): Draft guidance for industry.
Siegfried EC, Jaworski JC, Eichenfield LF, Paller A, Hebert AA, Simpson EL, Altman E, Arena C, Blauvelt A, Block J, Boguniewicz M, Chen S, Cordoro K, Hanna D, Horii K, Hultsch T, Lee J, Leung DY, Lio P, Milner J, Omachi T, Schneider C, Schneider L, Sidbury R, Smith T, Sugarman J, Taha S, Tofte S, Tollefson M, Tom WL, West DP, Whitney L, Zane L
Pediatric psoriasis: Evolving perspectives.
Eichenfield LF, Paller AS, Tom WL, Sugarman J, Hebert AA, Friedlander SF, Siegfried E, Silverberg N, Cordoro KM
Safety of Systemic Agents for the Treatment of Pediatric Psoriasis.
Bronckers IMGJ, Seyger MMB, West DP, Lara-Corrales I, Tollefson M, Tom WL, Hogeling M, Belazarian L, Zachariae C, MahÃ© E, Siegfried E, Philipp S, Szalai Z, Vleugels RA, Holland K, Murphy R, Baselga E, Cordoro K, Lambert J, Alexopoulos A, Mrowietz U, Kievit W, Paller AS, Psoriasis Investigator Group (PsIG) of the Pediatric Dermatology Research Alliance and the European Working Group on Pediatric Psoriasis (EWGPP).
Atopic dermatitis: emerging therapies.
Simpson E, Udkoff J, Borok J, Tom W, Beck L, Eichenfield LF
Pediatric Psoriasis Comorbidity Screening Guidelines.
Osier E, Wang AS, Tollefson MM, Cordoro KM, Daniels SR, Eichenfield A, Gelfand JM, Gottlieb AB, Kimball AB, Lebwohl M, Mehta NN, Paller AS, Schwimmer JB, Styne DM, Van Voorhees AS, Tom WL, Eichenfield LF
Prescribing practices for systemic agents in the treatment of severe pediatric atopic dermatitis in the US and Canada: The PeDRA TREAT survey.
Totri CR, Eichenfield LF, Logan K, Proudfoot L, Schmitt J, Lara-Corrales I, Sugarman J, Tom W, Siegfried E, Cordoro K, Paller AS, Flohr C
Visual Diagnosis: Spoon Nails and Short, Brittle Hair in a 3-year-old Boy.
Sorensen EP, Tom WL
Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults.
Paller AS, Tom WL, Lebwohl MG, Blumenthal RL, Boguniewicz M, Call RS, Eichenfield LF, Forsha DW, Rees WC, Simpson EL, Spellman MC, Stein Gold LF, Zaenglein AL, Hughes MH, Zane LT, Hebert AA
Psoriasiform eruptions during Kawasaki disease (KD): A distinct phenotype.
Haddock ES, Calame A, Shimizu C, Tremoulet AH, Burns JC, Tom WL
Characterization of Lipoprotein Composition and Function in Pediatric Psoriasis Reveals a More Atherogenic Profile.
Tom WL, Playford MP, Admani S, Natarajan B, Joshi AA, Eichenfield LF, Mehta NN
Ecthyma Gangrenosum-Like Lesions Secondary to Methicillin-Sensitive Staphylococcus aureus in an Immunocompetent Child.
Song SS, Matiz C, Tom WL, Calame A, Krakowski AC, Friedlander SF
Proceedings of the Inaugural Pediatric Dermatology Research Alliance (PeDRA) conference.
Siegel DH, Choate KA, Drolet BA, Frieden IJ, Rittenberg S, Teng JM, Tom WL, Williams ML, Eichenfield LF, Paller AS
Guidelines of care for the management of atopic dermatitis: Section 4. Prevention of disease flares and use of adjunctive therapies and approaches.
Sidbury R, Tom WL, Bergman JN, Cooper KD, Silverman RA, Berger TG, Chamlin SL, Cohen DE, Cordoro KM, Davis DM, Feldman SR, Hanifin JM, Krol A, Margolis DJ, Paller AS, Schwarzenberger K, Simpson EL, Williams HC, Elmets CA, Block J, Harrod CG, Smith Begolka W, Eichenfield LF
See the full listing of this physician's publications on PubMed, a service of the National Library of Medicine.
PubMed is a third-party website and not affiliated with Rady Children's Hospital-San Diego.
Rady Children's updates the Doctor Finder annually. We are not responsible for omissions or errors. Prior to making an appointment, please be sure to check with your health plan to confirm coverage. If you see an error or omission on a physician's profile page, please contact us at firstname.lastname@example.org.